Supplemental Figure 1 A No. at risk T3 530 483 304 185 50 T2 559 545 373 228 76 T1 540 532 375 208 64.

Slides:

Advertisements

Similar presentations

Supplemental figure 1 ROS production in MM cell line (KMM1) treated with bortezomib and DCA. ROS production was marginally increased by DCA in combination.

Advertisements

Facts and Figures Facts and Figures 2006 Facts and Figures 2006.

Supplemental images for Oklahoma archeology 56(2).

Figure 7.1 Genomes 3 (© Garland Science 2007) Figure 7.2 Genomes 3 (© Garland Science 2007)

P449. p450 Figure 15-1 p451 Figure 15-2 p453 Figure 15-2a p453.

©Brooks/Cole, 2001 Chapter 9 Pointers. ©Brooks/Cole, 2001 Figure 9-1.

© K. Cuthbertson and D. Nitzsche Figures for Chapter 12 FUTURES OPTIONS (Financial Engineering : Derivatives and Risk Management)

©Brooks/Cole, 2001 Chapter 8 Arrays. ©Brooks/Cole, 2001 Figure 8-1.

©Brooks/Cole, 2001 Chapter 3 Structure of a C Program.

© 2003 The McGraw-Hill Companies, Inc. All rights reserved. Risk Management: An Introduction to Financial Engineering Chapter Twenty- Three.

©Brooks/Cole, 2001 Chapter 10 Pointer Applications.

©Brooks/Cole, 2001 Chapter 11 Strings. ©Brooks/Cole, 2001 Figure 11-1.

Guts of GUT: Fact IV Growth category figures Supplemental material October 2010.

Figures from : Thompson, D.W.J., and J.M. Wallace, 2000: Annular modes in the extratropical circulation. Part I: Month-to-month variability. J. Climate,

P247. Figure 9-1 p248 Figure 9-2 p251 p251 Figure 9-3 p253.

©Brooks/Cole, 2001 Chapter 4 Functions. ©Brooks/Cole, 2001 Figure 4-1.

Figure Figure 18-1 part 1 Figure 18-1 part 2.

© 2003 The McGraw-Hill Companies, Inc. All rights reserved. Return, Risk, and the Security Market Line Chapter Thirteen.

Subgroup Vitamin C Active Group Placebo Group P value for Interaction Age yr (No. of cases) yr 158.

Supplemental Figure 1 Sham+Sham (N = 40) Sham+SPX (N = 40) AAC+Sham (N = 40) AAC+SPX (N = 40) AAC+SPX+IL-10 (N = 40) Day 2Day 4Day 14Day 28 echocardiography.

Supplemental Figure Legends Supplemental Figure 1a: SF-36. SF-36 mental component score among subjects randomized to SAMe or placebo, at baseline, Week.

VI-D-15(PP) Disassembly of the Small Engine Figure 1.

Supplemental Digital Content, Figure 1. Bland-Altman plots of intra- and inter-operator agreement for adiposity measurements. (A) Comparison of two reads.

Chapter 1: Definition and classification of CKD Kidney International Supplements Volume 3, Issue 1, Pages (January 2013) DOI: /kisup

MdSFBB3-alpha MSHVRESETPEDRVVEILSRLPPKSLMRFKCIHKSWFSLINNLSFVAKHLSNSVDNKLSSSTCILLNRSQAHIFPDQSWKQEVFWSMINFSIDSDENNLHYDVEDLN-IP 109 MdSFBB3-beta MSQVHESETPEDKVVEILCRLPPKSLMRFKCIRKSWCTLINRPSFVAKHLNNSVDNKLSSSTCILLNRSQAHIFPDQSWKQEVFWSTINLSIDSDEHNLHYDVEDLI-IP.

Leptin/Adiponectin Ratio

Supplemental Figures S1-S28

FIGURE 1. Adherence to the vitamin C study tablets (active and placebo) by percentiles in the pill-organizer and no organizer groups, TRACE Study, 1996–1997.

Copyright © 2013 American Medical Association. All rights reserved.

EPP Peak #1 Extraction 1 Extraction 2 Extraction 3 Gel 1 Gel 2

Supplementary Figure 1 Shiota et al.

ONLINE SUPPLEMENTAL MATERIAL

a b c d Supplemental Figure S x108 IFU 2x108 IFU 28 28

Supplemental Figures Supplemental Figure 1.

Applications of the Derivative

Figures & Tables from the textbook.

Frederik Persson, Peter Rossing Kidney International Supplements

بعض النقاط التي تؤخذ في الحسبان عند تقييم الاستثمارات الزراعية

بسم الله الرحمن الرحیم.

Supplemental Figure 1 A B C

Supplemental Figure S2: G2 arrest in MCF7-shPBK1 stable cell line

Groups 36 and 630 Group 640 Group 31 Group 5 Groups 40,41, 655 and 669

Supplemental Figure 1 1 mutation 2 mutations 3 mutations 4 mutations

OH C13 (ppm) H1 (ppm) Atom number

Nat. Rev. Endocrinol. doi: /nrendo

David J.A. Jenkins et al. JACC 2018;71:

Supplemental Figure 1A Pt Pt Pre-treatment

David J.A. Jenkins et al. JACC 2018;71:

Supplemental Figure 1. total n=862

Supplemental Figure 1 – Age Distribution in the CAC Consortium

Supplemental Figure 1 Patient 2.

Figure Overview.

Figure Overview.

Reh cells, 24 hours c-Myc Ac-p53 b-actin

Supplemental Figure 6 Effect of p. o

Supplemental Figure 1A SMM Patient #1 MP-CTL % CD3+ CD8+ T Cells

Chapter 4 Transients See notes on the chalkboard and the figures that follow.

Diagonal lines were shown.

Supplemental Fig 1 (A) (B) (B) 59% % alive 52% Years from entry 59%

Supplemental Figure S1 A B Adults Neonates Adult CD103+ DC: KdM282-90

resting state fMRI scan ( 8min 10sec )

David J.A. Jenkins et al. JACC 2018;71:

David J.A. Jenkins et al. JACC 2018;71:

Chapter 1 Functions.

David J.A. Jenkins et al. JACC 2018;71:

Chapter 77 Cervical Cancer: Burden of Disease

Presentation transcript:

Supplemental Figure 1 A No. at risk T T T

Supplemental Figure 1 B No. at risk T T T

Supplemental Figure 1 C No. at risk T T T

D Supplemental Figure 1 No. at risk T T T

E No. at risk T T T Supplemental Figure 1

F No. at risk T T T Supplemental Figure 1

G No. at risk T T T Supplemental Figure 1

Supplemental Figure 2